Assenagon Asset Management S.A. - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,337,123
+4.2%
407,290
-25.0%
0.03%
-6.5%
Q2 2023$8,957,533
-24.4%
543,210
-18.2%
0.03%
-26.2%
Q1 2023$11,846,224
+87662.8%
664,026
+43.3%
0.04%
-14.3%
Q4 2022$13,498
-99.9%
463,516
-1.5%
0.05%
+11.4%
Q3 2022$11,525,000
+302.7%
470,410
-31.8%
0.04%
+300.0%
Q2 2022$2,862,000
-64.8%
689,720
-2.3%
0.01%
-52.2%
Q1 2022$8,132,000
+19.0%
705,920
+3.1%
0.02%
+15.0%
Q4 2021$6,834,000
+4.2%
684,746
+36.3%
0.02%
-4.8%
Q3 2021$6,560,000
+135.1%
502,270
+252.5%
0.02%
+133.3%
Q2 2021$2,790,000142,4720.01%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$9,074,0001.96%
NEA Management Company, LLC 4,912,306$49,025,0000.99%
RA Capital Management 4,871,067$48,613,0000.86%
Samsara BioCapital, LLC 345,293$3,446,0000.67%
Endurant Capital Management LP 197,462$1,971,0000.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,867,467$18,637,0000.39%
ACT CAPITAL MANAGEMENT, LLC 27,500$274,0000.20%
Baker Brothers Advisors 3,863,239$38,555,0000.19%
Rock Springs Capital Management LP 627,180$6,259,0000.14%
Aquatic Capital Management LLC 4,000$40,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders